Roger Léger
Impact in
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
-
- Chemical Synthesis and Analysis 3
- Phenothiazines and Benzothiazines Synthesis and Activities 2
-
- Synthetic Organic Chemistry Methods 2
- Carbohydrate Chemistry and Synthesis 2
- Co-authors
- Suzanne Chamberland (7 shared papers)Ving J. Lee (7 shared papers)Olga Lomovskaya (6 shared papers)Scott J. Hecker (3 shared papers)Hiroko Ishida (2 shared papers)Kazuki Hoshino (2 shared papers)Angela Lee (1 shared paper)Mark S. Warren (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (8 papers)Journal of the American Chemical Society (2 papers)Endocrinology (1 paper)Tetrahedron Letters (1 paper)Synlett (1 paper)
- Partner nations
- United StatesJapanCanada
In The Last Decade
Roger Léger
19 papers receiving 1.5k citations
Roger Léger's Hit Papers
Peers
Comparison fields: 5 of 84
- Molecular Medicine 981
- Pharmacology 443
- Endocrinology 122
- Applied Microbiology and Biotechnology 40
- Microbiology 117
Countries citing papers authored by Roger Léger
This map shows the geographic impact of Roger Léger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Léger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Léger more than expected).
Fields of papers citing papers by Roger Léger
This network shows the impact of papers produced by Roger Léger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Léger. The network helps show where Roger Léger may publish in the future.
Co-authors
The 25 scholars most cited alongside Roger Léger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Identification and Characterization of Inhibitors of Multidrug Resistance Efflux Pumps in Pseudomonas aeruginosa : Novel Agents for Combination Therapy Hit paper breakdown → | 2001 | 731 |
| 2 | 1999 | 219 | |
| 3 | 2003 | 76 | |
| 4 | 2003 | 66 | |
| 5 | 2003 | 64 | |
| 6 | 2002 | 60 | |
| 7 | 1992 | 53 | |
| 8 | 2004 | 52 | |
| 9 | 2001 | 50 | |
| 10 | 2001 | 43 | |
| 11 | 2005 | 38 | |
| 12 | 2005 | 34 | |
| 13 | 1997 | 22 | |
| 14 | 2020 | 18 | |
| 15 | 1992 | 17 | |
| 16 | 2003 | 16 | |
| 17 | 2004 | 15 | |
| 18 | 1992 | 3 | |
| 19 | 1992 | 1 |
About Roger Léger
Roger Léger is a scholar working on Molecular Biology, Organic Chemistry, Molecular Medicine, Pharmacology and Oncology, having authored 19 papers that have together received 1.6k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (6 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Chemical Synthesis and Analysis (3 papers), Peptidase Inhibition and Analysis (2 papers), Phenothiazines and Benzothiazines Synthesis and Activities (2 papers), Synthetic Organic Chemistry Methods (2 papers), Carbohydrate Chemistry and Synthesis (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Molecular Medicine (981 citations), Pharmacology (443 citations), Endocrinology (122 citations), Applied Microbiology and Biotechnology (40 citations) and Microbiology (117 citations). Roger Léger has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Suzanne Chamberland, Ving J. Lee, Olga Lomovskaya, Scott J. Hecker, Hiroko Ishida, Kazuki Hoshino, Angela Lee, Mark S. Warren, Johanne Blais and May Lee. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of the American Chemical Society, Endocrinology, Tetrahedron Letters and Synlett.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.